Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study

Acta Neurologica Scandinavica

Volumn 85, Issue 2, 1992, Pages 81-89

  Ludolph, A C ^a   Langen, K J ^c   Regard, M ^c   Herzog, H ^c   Kemper, B ^a   Kuwert, T ^c   Bottger I G ^b   Feinendegen, L ^c  

^a Departments of Neurology   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD GLUCOSE; BRAIN MAPPING; BULBAR PALSY, PROGRESSIVE; CEREBRAL CORTEX; DEMENTIA; FEMALE; FRONTAL LOBE; HUMAN; MALE; MIDDLE AGE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0026515287     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1992.tb04003.x     Document Type: Article

References (50)

1. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis
2. et al. Guam amyotrophic lateral sclerosis‐parkinsonism‐dementia linked to a plant excitant neurotoxin
3. Motoneuron disease and past poliomyelitis in England and Wales
4. et al. Motor neuron disease and plasma cell dycrasia
5. Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials
6. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis
7. ALS in Japan
8. Cognitive impairment in motor neuron disease
9. Neuro‐psychological, electroencephalogram and brain computed tomography findings in motor neuron disease
10. Neuro‐psychological measures in amyotrophic lateral sclerosis and their relationship with CT scan‐assessed cerebral atrophy
11. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorder: a review
12. The central nervous system in motor neurone disease
13. The administration of guanidine in amyotrophic lateral sclerosis
14. Efficient stereospecific synthesis of no‐carrier‐added 2‐(18F)‐fluoro‐2‐deoxy‐D‐glucose using aminopropylether supported nucleo‐philic substitution
15. The (18F)‐fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man
16. The(14C)deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat
17. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for (18F)fluorodeoxy‐glucose and (11C)deoxyglucose
18. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease
19. Cerebral glucose utilization as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years
20. Global cerebral glucose utilization is independent of brain size: a PET study
21. An inventory for measuring depression
22. Effects of different brain lesions on card sorting
23. Some effects of frontal lobectomy in man
24. Children's production on verbal and non‐verbal fluency tasks
25. Studies of interference in serial verbal reactions
26. Le test de copie d'une figure complex
27. Response latencies in naming objects
28. Positron emission tomography studies in the brain. In: Positron emission tomography and autoradiography
29. Cerebral circulation, energy metabolism, and protein synthesis: general characteristics and principles of measurement
30. Positron emission tomography and computed tomography assessments of the aging human brain
31. Positron emission tomography studies of normal aging: a replication of PET III and 18‐FDG using PET VI and 11‐CDG
32. Brain glucose metabolism and memory functions: age decrease in factor scores
33. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors
34. Cerebral glucose metabolic rates in normal human females versus normal males
35. Cortical motor‐sensory hypometabolism in amyotrophic lateral sclerosis
36. Ganglioside patterns in amyotrophic lateral sclerosis brain regions
37. Die myatrophische Lateralsklerose
38. Basal ganglia glucose utilization after recent precentral ablation in the monkey
39. Thalamic, brainstem, and cerebellar glucose metabolism in the hemiplegic monkey
40. Normal cerebral glucose utilization in amyotrophic lateral sclerosis
41. Dopaminergic deficits demonstrated in Caucasian amyotrophic lateral sclerosis using positron emission tomography
42. Frontal lobe dementia and motor neuron disease